Anirban Pal

About

My primary area of vocation is the development and standardization of a small animal model to evaluate bioactive(s) for their therapeutic efficacy and toxicity profile. I have developed an inclination towards the infectious diseases and wish to prospect molecules from medicinal plants that could be antibacterial, antifungal or antimalarial. My major project area is prospection of medicinal plants for their possible anti-malarial activity through in-vitro and in-vivo methods. Besides, I have also honed my skills on the animal models of typhoid and candidiasis. While working on both parasite and bacteria, we have also standardized a co-infection model Plasmodium-Salmonella in mice. Since the immune system is intricately involved in any infectious condition, my secondary area of interest is to look into the modulation of the immune system to overcome the disease condition. As support to other institutional projects, I also evaluate molecules for anti-staphylococcal, anti-salmonella and anti-candidal activity in rodent models. My scientific career would be worth if I could translate all my science into products or know-how’s for human welfare, which I have been focusing upon and have been partially successful.

Employment

• Department of Scientific and Industrial Research Chief Scientist and Head, Central Planning Directorate
  2025 - Present
• Council of Scientific & Industrial Research Chief Scientist / Professor
  2001 - Present

Education

• ICAR-Indian Veterinary Research Institute Ph.D.
  1996 - 2000
• Odisha University of Agriculture and Technology B.V.Sc.& A.H., M.V.Sc.
  1988 - 1995

Projects & Funding

Projects & funding information is unavailable.

Publications (88)

• Cu-catalyzed click reaction in synthesis of eugenol derivatives as potent antimalarial agents
  Natural Product Research 2025 DOI: 10.1080/14786419.2024.2348670
  +Save
• Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310
  Drugs and Drug Candidates 2025 DOI: 10.3390/ddc5010002
  +Save
• A Mechanistic Insight into the Anti-Staphylococcal Mode of Action of (+)-Usnic Acid and Its Synergy with Norfloxacin Against Methicillin-Resistant Staphylococcus aureus
  Biomolecules 2025 DOI: 10.3390/biom15060750
  +Save
• Mechanistic Insight into the Antimicrobial Mode of Action of Usnic Acid and Its Synergy with Norfloxacin against Methicillin-Resistant Staphylococcus aureus
  2024 DOI: 10.20944/preprints202407.2326.v1
  +Save
• Radiocarbon (14C) accelerator mass spectrometry as a convenient tool for differentiation of flavor chemicals of synthetic origin from biobased sources and their in-vivo toxicity assessment
  Science of The Total Environment 2024 DOI: 10.1016/j.scitotenv.2023.168357
  +Save
• Effect of liquiritigenin on chloroquine accumulation in digestive vacuole leading to apoptosis-like death of chloroquine-resistant P. falciparum
  Phytomedicine 2023 DOI: 10.1016/j.phymed.2023.154738
  +Save
• Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus
  Drugs and Drug Candidates 2023 DOI: 10.3390/ddc2020016
  +Save
• 4-Chlorothymol Exerts Antiplasmodial Activity Impeding Redox Defense System in Plasmodium falciparum
  Frontiers in Pharmacology 2021 DOI: 10.3389/fphar.2021.628970
  +Save
• 4-chloro eugenol interacts synergistically with artesunate against drug resistant P. falciparum inducing oxidative stress
  Biomedicine and Pharmacotherapy 2021 DOI: 10.1016/j.biopha.2021.111311
  +Save
• Chemical characterization of winged bean (Psophocarpus tetragonolobus (L.) DC. seeds and safety evaluation of its fatty oil
  Journal of Food Measurement and Characterization 2021 DOI: 10.1007/s11694-020-00680-1
  +Save